Clinical trial
An Open-Label Study of Aripiprazole in Children and Adolescents With Autistic Disorder
NCT00198055 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label Study of Aripiprazole in Children and Adolescents With Autistic Disorder
- Lead sponsor
- Indiana University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 2005
- Completion date
- September 30, 2007
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
asperger's disorder, pervasive developmental disorder